MedPath

Evaluation of the effect of portulaca oleracea syrup on hot flashes

Phase 3
Recruiting
Conditions
Hot flashes.
Menopausal and female climacteric states
N95.1
Registration Number
IRCT20200112046087N7
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
84
Inclusion Criteria

Menopausal women over 45 years
Stop menstruation for 12 months or more or less than 12 months with follicle-stimulating hormone
Having hot flashes at least twice a day
Serum FSH more than 40 international units according to laboratory reports
Serum LH more than 30 international units according to laboratory reports

Exclusion Criteria

Known physical and mental illnesses such as depression, diabetes, cardiovascular disease, hypertension, hyperlipidemia, liver disease, blood diseases, cancer, gastrointestinal diseases
Use of hormone therapy, anticoagulants, sedatives, antidepressants, anticonvulsants, alpha-adrenergic agonists such as clonidine
Use plant phytoestrogens such as fennel, soy, black cohosh, flax, primrose oil and vitamin E over the past 8 weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of hot flashes. Timepoint: 2-week monitoring on a daily basis. Method of measurement: Heater et al Scale Questionnaire.;Duration of hot flashes. Timepoint: 2-week monitoring on a daily basis. Method of measurement: Heater et al Scale Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath